Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targin for Opioid-Induced Constipation in Non-Malignant Pain
NCT01918098Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Sep 2013
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone in opioid-induced constipation (OIC), Chronic non-malignant pain (CNMP), sponsored by Mundipharma. Started Sep 2013; status: completed.
02
Drugs
oxycodone
03
Conditions
opioid-induced constipation (OIC)Chronic non-malignant pain (CNMP)
Beyond the preview
Go deeper on NCT01918098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01918098.